Cargando…

Recurrence of atrial fibrillation after switching from brand to generic atenolol

Beta blockers are the initial treatment for rate control of supraventricular tachyarrhythmia in patients without a history of myocardial infarction or left ventricular dysfunction. In this article we report the recurrence of atrial fibrillation after switching to the generic formulation of atenolol.

Detalles Bibliográficos
Autores principales:	Gallelli, Luca, Maida, Francesca, Staltari, Orietta, Rende, Pierandrea, Russo, Emilio, Caroleo, Benedetto, De Sarro, Giovambattista
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319249/ https://www.ncbi.nlm.nih.gov/pubmed/25709353 http://dx.doi.org/10.4103/0976-500X.149146

Ejemplares similares

Pegylated interferon/telbivudine sequential therapy in Hepatitis Be antigen negative severe chronic hepatitis B patient
por: Caroleo, Benedetto, et al.
Publicado: (2013)

A Case of Interstitial Lung Disease Probably Related to Rituximab Treatment
por: Calderazzo, Massimo, et al.
Publicado: (2015)

Safety and efficacy of generic drugs with respect to brand formulation
por: Gallelli, Luca, et al.
Publicado: (2013)

Annual report on adverse events related with vaccines use in Calabria (Italy): 2012
por: Staltari, Orietta, et al.
Publicado: (2013)

Pharmacovigilance and drug safety in Calabria (Italy): 2012 adverse events analysis
por: Giofrè, Chiara, et al.
Publicado: (2013)

Skin rash during treatment with generic itraconazole
por: De Vuono, Antonio, et al.
Publicado: (2014)

Appearances of Premature Atrial and Ventricular Contractions After Switching From Brand Name to Generic Cibenzoline
por: Oguri, Gaku, et al.
Publicado: (2023)

Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study
por: Desai, Rishi J, et al.
Publicado: (2018)

Exosome microRNAs in Metabolic Syndrome as Tools for the Early Monitoring of Diabetes and Possible Therapeutic Options
por: Cione, Erika, et al.
Publicado: (2021)

Potential Clinical and Economic Impact of Switching Branded Medications to Generics
por: Straka, Robert J., et al.
Publicado: (2017)

The safety of ketoprofen in different ages
por: Carbone, Claudia, et al.
Publicado: (2013)

Safety of switching from brand-name to generic levetiracetam in patients with epilepsy
por: Bosak, Magdalena, et al.
Publicado: (2017)

Brand and generic medications: Are they interchangeable?
por: Al-Jazairi, Abdulrazaq S., et al.
Publicado: (2008)

Prescription writing: Generic or brand?
por: Andrade, Chittaranjan, et al.
Publicado: (2017)

Brand Name Versus Generic?
por: Aungaroon, Gewalin
Publicado: (2023)

Asterixis as a Presentation of Cerebellar Ischemic Stroke
por: Siniscalchi, Antonio, et al.
Publicado: (2012)

Predicting Cost‐Effectiveness of Generic vs. Brand Dabigatran Using Pharmacometric Estimates Among Patients with Atrial Fibrillation in the United States
por: Wang, Ching‐Yu, et al.
Publicado: (2020)

Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis
por: Scicchitano, Francesca, et al.
Publicado: (2012)

Management of Lipedema with Ketogenic Diet: 22-Month Follow-Up
por: Cannataro, Roberto, et al.
Publicado: (2021)

Switching from branded to generic glatiramer acetate: 15-month GATE trial extension results
por: Selmaj, Krzysztof, et al.
Publicado: (2017)

Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients
por: Gianotti, Nicola, et al.
Publicado: (2017)

Pharmacovigilance in Calabria (Italy): Local experiences resonate international relevance
por: Russo, Emilio, et al.
Publicado: (2013)

Evaluation of Physical Properties of Generic and Branded Travoprost Formulations
por: Wadhwani, Meenakshi, et al.
Publicado: (2016)

Design and rationale for the WARFA trial: a randomized controlled cross-over trial testing the therapeutic equivalence of branded and generic warfarin in atrial fibrillation patients in Brazil
por: Freitas, Carolina Gomes, et al.
Publicado: (2017)

Are Branded and Generic Extended-Release Ropinirole Formulations Equally Efficacious? A Rater-Blinded, Switch-Over, Multicenter Study
por: Bosnyák, Edit, et al.
Publicado: (2014)

Public Health Outcomes May Differ After Switching from Brand-Name to Generic Angiotensin II Receptor Blockers
por: Leclerc, Jacinthe, et al.
Publicado: (2020)

Analysis of antiviral efficacy after switching from brand to generic entecavir in patients with treatment-naïve chronic hepatitis B
por: Hsu, Po-Ke, et al.
Publicado: (2022)

Interactions among Low Dose of Methotrexate and Drugs Used in the Treatment of Rheumatoid Arthritis
por: Patanè, Marinella, et al.
Publicado: (2013)

Serological Response to SARS-CoV-2 Messenger RNA Vaccine: Real-World Evidence from Italian Adult Population
por: Papadopoli, Rosa, et al.
Publicado: (2021)

Cyclosporine: A Commentary on Brand versus Generic Formulation Exchange
por: Singh, A. K., et al.
Publicado: (2011)

A critical review of brand and generic alendronate for the treatment of osteoporosis
por: Brown, Jacques P, et al.
Publicado: (2013)

Generic versus brand-name drugs used in cardiovascular diseases
por: Manzoli, Lamberto, et al.
Publicado: (2015)

Assessment of the equivalence of a generic to a branded femoral stem
por: Hothi, H., et al.
Publicado: (2017)

Bioequivalence of generic and branded amoxicillin capsules in healthy human volunteers
por: Pathak, Priyanka, et al.
Publicado: (2017)

HPLC-Based Analysis of Impurities in Sapropterin Branded and Generic Tablets
por: Scudellaro, Emanuela, et al.
Publicado: (2020)

Generics versus brand-named drugs for glaucoma: the debate continues
por: Bhartiya, Shibal, et al.
Publicado: (2020)

Pharmacist Intervention in Safe and Effective Conversion of Brand to Generic Drugs
por: Summers, Kent H.
Publicado: (2005)

Retrospective evaluation of adverse drug reactions induced by antihypertensive treatment
por: Rende, Pierandrea, et al.
Publicado: (2013)

A comparative evaluation of price and quality of some branded versus branded–generic medicines of the same manufacturer in India
por: Singal, G.L., et al.
Publicado: (2011)

Automatic mode switching in atrial fibrillation
por: Stabile, Giuseppe, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_ojvq35g9rppog9str2ftqjiaup